Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
Sales | 16,497 | 14,067 | 11,425 | 8,400 | 7,538 |
Cost of Goods | 12,976 | 9,321 | 8,147 | 6,218 | 5,153 |
Gross Profit | 3,521 | 4,746 | 3,278 | 2,182 | 2,385 |
Operating Expenses | 7,949 | 7,157 | 6,449 | 7,389 | 7,315 |
Operating Income | -3,452 | -2,090 | -3,024 | -4,989 | -4,777 |
Interest Expense | 243 | 264 | 231 | -1,414 | 571 |
Other Income | 87 | 70 | 42 | 104 | 138 |
Pre-tax Income | -3,608 | -2,284 | -3,213 | -3,471 | -5,210 |
Net Income Continuous | -3,608 | -2,284 | -3,213 | -3,471 | -5,210 |
Net Income | $-3,608 | $-2,284 | $-3,213 | $-3,471 | $-5,210 |
EPS Basic Total Ops | -0.07 | -0.05 | -0.07 | -0.06 | -0.11 |
EPS Basic Continuous Ops | -0.07 | -0.05 | -0.07 | -0.07 | -0.11 |
EPS Diluted Total Ops | -0.07 | -0.05 | -0.07 | -0.06 | -0.11 |
EPS Diluted Continuous Ops | -0.07 | -0.05 | -0.07 | -0.07 | -0.11 |
EBITDA(a) | $-2,516 | $-1,193 | $-2,139 | $-4,055 | $-4,036 |